NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 59 filers reported holding NIVALIS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,385,000 | +76.7% | 170,400 | 0.0% | 0.47% | +50.3% |
| Q2 2016 | $784,000 | +10.3% | 170,400 | 0.0% | 0.31% | +6.4% |
| Q1 2016 | $711,000 | -46.1% | 170,400 | 0.0% | 0.30% | -20.5% |
| Q4 2015 | $1,319,000 | -40.3% | 170,400 | 0.0% | 0.37% | -12.3% |
| Q3 2015 | $2,210,000 | -24.2% | 170,400 | -11.4% | 0.42% | +53.8% |
| Q2 2015 | $2,915,000 | – | 192,400 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|